Neuropathology of bipolar disorder

[1]  H. Beckmann.  Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia Schizophrenia Research 33 (1998) 125–132 , 2002, Schizophrenia Research.

[2]  J. Cummings,et al.  Frontal-subcortical circuits in psychiatric and neurological disorders , 2001 .

[3]  S. Salloway,et al.  The frontal lobes and neuropsychiatric illness , 2001 .

[4]  C. Nelson,et al.  Handbook of Developmental Cognitive Neuroscience , 2001 .

[5]  Ellen Frank,et al.  Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder , 2000, Biological Psychiatry.

[6]  G. Moore,et al.  Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. , 2000, The Journal of clinical psychiatry.

[7]  D. Papolos.  The Bipolar Child: The Definitive and Reassuring Guide to Childhood's Most Misunderstood Disorder , 2000 .

[8]  D. Watson.  Mood and temperament , 2000 .

[9]  J. Borod.  The Neuropsychology of emotion , 2000 .

[10]  L. Altshuler,et al.  A preliminary study of the relation of neuropsychological performance to neuroanatomic structures in bipolar disorder. , 2000, Neuropsychiatry, neuropsychology, and behavioral neurology.

[11]  R J Wyatt,et al.  Elevated concentration of N-CAM VASE isoforms in schizophrenia. , 2000, Journal of psychiatric research.

[12]  C. Qualls,et al.  CSF SNAP-25 in Schizophrenia and Bipolar Illness A Pilot Study , 1999, Neuropsychopharmacology.

[13]  Elizabeth Gould,et al.  Stress and hippocampal neurogenesis , 1999, Biological Psychiatry.

[14]  J. Parrish,et al.  Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. , 1999, The American journal of psychiatry.

[15]  K. Ressler,et al.  Role of norepinephrine in the pathophysiology and treatment of mood disorders , 1999, Biological Psychiatry.

[16]  S. Kish,et al.  Increased Cyclic AMP‐Dependent Protein Kinase Activity in Postmortem Brain from Patients with Bipolar Affective Disorder , 1999, Journal of neurochemistry.

[17]  A. Rush,et al.  Hippocampal Remodeling and Damage by Corticosteroids: Implications for Mood Disorders , 1999, Neuropsychopharmacology.

[18]  G. Pearlson.  Structural and functional brain changes in bipolar disorder: a selective review , 1999, Schizophrenia Research.

[19]  G. MacQueen,et al.  G Protein‐Coupled Cyclic AMP Signaling in Postmortem Brain of Subjects with Mood Disorders , 1999, Journal of neurochemistry.

[20]  J. Kleinman,et al.  Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia , 1999, Molecular Psychiatry.

[21]  D. Lam,et al.  Cognitive Therapy for Bipolar Disorder: A Therapist's Guide to Concepts, Methods and Practice , 1999 .

[22]  B. Bogerts,et al.  Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. , 1999, Journal of affective disorders.

[23]  Melissa P. DelBello,et al.  MRI Analysis of the Cerebellum in Bipolar Disorder: A Pilot Study , 1999, Neuropsychopharmacology.

[24]  Y. Hurd,et al.  Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. , 1999, Neuroreport.

[25]  D. Senitz,et al.  A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. , 1999, Biological psychiatry.

[26]  J. Klein,et al.  Adrenergic modulation of astroglial phospholipase D activity and cell proliferation , 1999, Brain Research.

[27]  J. Kleinman,et al.  Evaluation of superior vermal Purkinje cell placement in mental illness , 1999, Biological Psychiatry.

[28]  Deborah A Yurgelun-Todd,et al.  Differences in cerebellar blood volume in schizophrenia and bipolar disorder , 1999, Schizophrenia Research.

[29]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[30]  J. P. Schwartz,et al.  CNS interleukin-3 (IL-3) expression and neurological syndrome in antisense-IL-3 transgenic mice. , 1999, Journal of neuropathology and experimental neurology.

[31]  K. Krishnan,et al.  Hyperintense lesions on magnetic resonance images in bipolar disorder , 1999, Biological Psychiatry.

[32]  Paul J. Harrison.  The neuropathology of schizophrenia , 2008 .

[33]  S. Strakowski,et al.  Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. , 1999, Archives of general psychiatry.

[34]  P. Greengard,et al.  Synapsins as regulators of neurotransmitter release. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  B. Bogerts,et al.  Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[36]  C. Lupica,et al.  Opioid Receptor Subtype Expression Defines Morphologically Distinct Classes of Hippocampal Interneurons , 1999, The Journal of Neuroscience.

[37]  Paul J. Harrison,et al.  Expression of the 5-HT7 receptor in schizophrenia , 1999 .

[38]  L. Peterson,et al.  The Complete Adult Psychotherapy Treatment Planner , 1999 .

[39]  Derryck H. Smith,et al.  INS Dictionary of Neuropsychology. , 1999 .

[40]  M. Webster,et al.  Immunohistochemical localization of the cell adhesion molecules Thy-1 and L1 in the human prefrontal cortex: patients with schizophrenia, bipolar disorder, and depression , 1999, Molecular Psychiatry.

[41]  P. Falkai,et al.  Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia , 1998, Neuroscience Letters.

[42]  L. Schärer,et al.  Abnormal G protein αs- and αi2-subunit mRNA expression in bipolar affective disorder , 1998, Molecular Psychiatry.

[43]  J. Kleinman,et al.  VASE-Containing N-CAM Isoforms Are Increased in the Hippocampus in Bipolar Disorder but Not Schizophrenia , 1998, Experimental Neurology.

[44]  J. Kleinman,et al.  Alpha2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals , 1998, Biological Psychiatry.

[45]  E. Bock,et al.  The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system , 1998, Experimental Gerontology.

[46]  F. Gage,et al.  Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.

[47]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Sótonyi,et al.  Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides , 1998, Molecular Psychiatry.

[49]  E. Smeraldi,et al.  Effects of Lithium on cAMP-Dependent Protein Kinase in Rat Brain , 1998, Neuropsychopharmacology.

[50]  F. Benes,et al.  A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives , 1998, Biological Psychiatry.

[51]  R. Papke,et al.  Neurobiology of lithium: an update. , 1998, The Journal of clinical psychiatry.

[52]  D. Shields,et al.  Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase alpha subunit gene (ATP1A3) , 1998, Biological Psychiatry.

[53]  G. Bartzokis,et al.  Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. , 1998, Archives of general psychiatry.

[54]  W. Freed,et al.  Further Studies of Elevated Cerebrospinal Fluid Neuronal Cell Adhesion Molecule in Schizophrenia , 1998, Biological Psychiatry.

[55]  J. Price,et al.  Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders , 1998, Molecular Psychiatry.

[56]  J. Price,et al.  Reduced glucose metabolism in the subgenual prefrontal cortex in unipolar depression , 1998, Molecular Psychiatry.

[57]  J. Kesslak,et al.  Spatial learning and physical activity contribute to the induction of fibroblast growth factor: neural substrates for increased cognition associated with exercise , 1998, Neuroscience.

[58]  G M Edelman,et al.  Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Kleinman,et al.  Abnormal Expression of Cell Recognition Molecules in Schizophrenia , 1998, Experimental Neurology.

[60]  L. Schärer,et al.  Abnormal G protein alpha(s) - and alpha(i2)-subunit mRNA expression in bipolar affective disorder. , 1998, Molecular psychiatry.

[61]  W. Drevets,et al.  Functional neuroimaging studies of depression: the anatomy of melancholia. , 1998, Annual review of medicine.

[62]  G. Ordway,et al.  Pathophysiology of the Locus Coeruleus in Suicide a , 1997, Annals of the New York Academy of Sciences.

[63]  R. Saunders,et al.  A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. , 1997, Cerebral cortex.

[64]  G. Rajkowska.  Morphometric Methods for Studying the Prefrontal Cortex in Suicide Victims and Psychiatric Patients , 1997, Annals of the New York Academy of Sciences.

[65]  H. Meltzer,et al.  Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.

[66]  H. Cameron,et al.  Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway , 1997, Neuroscience.

[67]  P. Videbech.  MRI findings in patients with affective disorder: a meta‐analysis , 1997, Acta psychiatrica Scandinavica.

[68]  J. Luby,et al.  Child and adolescent bipolar disorder: a review of the past 10 years. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[69]  J. Kleinman,et al.  Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. , 1997, The American journal of psychiatry.

[70]  R. Ancill,et al.  The Relationship of Endogenous Cortisol to Psychiatric Disorder: A Review , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[71]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[72]  G. Edelman,et al.  Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Kish,et al.  Increased Gαq/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder , 1997, Biological Psychiatry.

[74]  E. Torrey,et al.  Monozygotic twins discordant for schizophrenia are discordant for N-CAM and L1 in CSF , 1997, Brain Research.

[75]  S. Kish,et al.  Reduced [3H]Cyclic AMP Binding in Postmortem Brain from Subjects with Bipolar Affective Disorder , 1997, Journal of neurochemistry.

[76]  J. Soares,et al.  The anatomy of mood disorders—review of structural neuroimaging studies , 1997, Biological Psychiatry.

[77]  S. Looney,et al.  Meta‐analysis of erythrocyte Na,K‐ATPase activity in bipolar illness , 1997, Depression and anxiety.

[78]  S. Kish,et al.  Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. , 1997, Biological psychiatry.

[79]  N. Perrone-Bizzozero,et al.  Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[80]  S. Kish,et al.  Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. , 1996, Brain research. Molecular brain research.

[81]  P. Kehrli,et al.  Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain , 1996, Brain Research.

[82]  A. Rush,et al.  The dexamethasone suppression test in patients with mood disorders. , 1996, The Journal of clinical psychiatry.

[83]  Hoau Yan Wang,et al.  Enhanced protein kinase C activity and translocation in bipolar affective disorder brains , 1996, Biological Psychiatry.

[84]  A. Lüthi,et al.  Reduction of hippocampal long‐term potentiation in transgenic mice ectopically expressing the neural cell adhesion molecule L1 in astrocytes , 1996, Journal of neuroscience research.

[85]  R. Jope,et al.  Phosphoinositide signaling in human brain , 1996, Progress in Neurobiology.

[86]  Eric R. Kandel,et al.  Cell Adhesion Molecules, CREB, and the Formation of New Synaptic Connections , 1996, Neuron.

[87]  Hoau Yan Wang,et al.  Receptor‐Mediated Activation of G Proteins Is Increased in Postmortem Brains of Bipolar Affective Disorder Subjects , 1996, Journal of neurochemistry.

[88]  T. Magnuson,et al.  Targeted mutation of Ncam to produce a secreted molecule results in a dominant embryonic lethality. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[89]  H. Meltzer,et al.  Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain , 1996, Brain Research.

[90]  S. Kish,et al.  The Phosphoinositide Signal Transduction System Is Impaired in Bipolar Affective Disorder Brain , 1996, Journal of neurochemistry.

[91]  E. Young,et al.  Hypercortisolemia, hippocampal glucocorticoid receptors, and fast feedback. , 1996, Molecular psychiatry.

[92]  M. Frye,et al.  Increased Neural Cell Adhesion Molecule in the CSF of Patients with Mood Disorder , 1996, Journal of neurochemistry.

[93]  A. Davies.  The neurotrophic hypothesis: where does it stand? , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[94]  D. Swaab,et al.  Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. , 1996, Archives of general psychiatry.

[95]  V. Arango,et al.  Fewer pigmented locus coeruleus neurons in suicide victims: Preliminary results , 1996, Biological Psychiatry.

[96]  D. Dormont,et al.  Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains , 1996, Glia.

[97]  O. Jørgensen.  SNAP‐25 is the major immunoreactive component of the brain‐specific D3 protein , 1995, Neuroreport.

[98]  Ove Wiborg,et al.  Serotonin depletion decreases serotonin transporter mRNA levels in rat brain , 1995, Brain Research.

[99]  M. Frotscher,et al.  Developmental upregulation of the neural cell adhesion molecule VASE exon in slice cultures of rat hippocampus , 1995, Neuroscience Letters.

[100]  H. Meltzer,et al.  Neuropeptide Y in Frontal Cortex Is Not Altered in Major Depression , 1995, Journal of neurochemistry.

[101]  E. Goldner,et al.  Evidence-Based Psychiatry , 1995, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[102]  W. Freed,et al.  Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia , 1995, Experimental Neurology.

[103]  N. Perrone-Bizzozero,et al.  Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method. , 1995, Molecular and chemical neuropathology.

[104]  K. Jamison.  An Unquiet Mind , 1996, Nature Medicine.

[105]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[106]  V. Arango,et al.  Fewer pigmented neurons in the locus coeruleus of uncomplicated alcoholics , 1994, Brain Research.

[107]  J. Glowinski,et al.  Glial receptors and their intervention in astrocyto–astrocytic and astrocyto–neuronal interactions , 1994, Glia.

[108]  J. Warsh,et al.  Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. , 1994, American Journal of Psychiatry.

[109]  S. Kish,et al.  Cerebral cortex β-adrenoceptor binding in bipolar affective disorder , 1994 .

[110]  P. Rakic,et al.  Neurons and astroglia express distinct subsets of Na,K-ATPase α and β subunits , 1994 .

[111]  S. Kish,et al.  Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder , 1994, Biological Psychiatry.

[112]  S. Kish,et al.  Cerebral cortex beta-adrenoceptor binding in bipolar affective disorder. , 1994, Journal of affective disorders.

[113]  K. Dib,et al.  Cyclic AMP regulation of messenger RNA level of the stimulatory GTP-binding protein Gs alpha. Isoproterenol, forskolin and 8-bromoadenosine 3':5'-cyclic monophosphate increase the level of Gs alpha mRNA in cultured astroglial cells. , 1994, European journal of biochemistry.

[114]  E. Azmitia,et al.  Astroglial 5-HT1a receptors and S-100 beta in development and plasticity. , 1994, Perspectives on developmental neurobiology.

[115]  A. Faissner,et al.  Tenascin glycoproteins in developing neural tissues: only decoration? , 1994, Perspectives on developmental neurobiology.

[116]  P. Rakić,et al.  Neurons and astroglia express distinct subsets of Na,K-ATPase alpha and beta subunits. , 1994, Brain research. Molecular brain research.

[117]  E. Bock,et al.  Cyclic AMP regulates NCAM expression and phosphorylation in cultured mouse astrocytes. , 1993, European Journal of Cell Biology.

[118]  S. Kish,et al.  Cerebral Cortex Gsα Protein Levels and Forskolin‐Stimulated Cyclic AMP Formation Are Increased in Bipolar Affective Disorder , 1993, Journal of neurochemistry.

[119]  T. Katada,et al.  Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholics , 1993, Brain Research.

[120]  R. Akeson,et al.  Axon growth is enhanced by NCAM lacking the VASE exon when expressed in either the growth substrate or the growing axon , 1993, Journal of neuroscience research.

[121]  M. Meaney,et al.  Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease. , 1993, Brain research. Molecular brain research.

[122]  R. Akeson,et al.  Distinct NCAM splicing events are differentially regulated during rat brain development. , 1993, Brain research. Molecular brain research.

[123]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[124]  F. Walsh,et al.  Use of the Neural Cell Adhesion Molecule VASE Exon by Neurons Is Associated with a Specific Down‐Regulation of Neural Cell Adhesion Molecule‐Dependent Neurite Outgrowth in the Developing Cerebellum and Hippocampus , 1992, Journal of neurochemistry.

[125]  J. Kleinman,et al.  Normal nucleolar size of entorhinal cortex cells in Schizophrenia , 1992, Psychiatry Research.

[126]  F. Walsh,et al.  The VASE exon downregulates the neurite growth-promoting activity of NCAM 140 , 1992, Nature.

[127]  J. Kleinman,et al.  Distribution of beta‐adrenergic receptor subtypes in human post‐mortem brain: Alterations in limbic regions of schizophrenics , 1992, Synapse.

[128]  James C. Ehrhardt,et al.  Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study , 1992, Biological Psychiatry.

[129]  N. Uranova,et al.  Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. , 1992, Neuroscience and behavioral physiology.

[130]  E. Nestler,et al.  Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[131]  I. Ferrier,et al.  Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates , 1991, Psychiatry Research.

[132]  S. Kish,et al.  Postmortem cerebral cortex Gs α-subunit levels are elevated in bipolar affective disorder , 1991, Brain Research.

[133]  B T Hyman,et al.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. , 1991, Archives of general psychiatry.

[134]  L. Altshuler,et al.  Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. , 1991, Archives of general psychiatry.

[135]  S. Kish,et al.  Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder. , 1991, Brain research.

[136]  J. Kleinman,et al.  The neuropathology of schizophrenia: A critical assessment of research methodologies , 1990, Biological Psychiatry.

[137]  F. Goodwin.  Manic-Depressive Illness , 1990 .

[138]  H. Meltzer.  Serotonergic Dysfunction in Depression , 1989, British Journal of Psychiatry.

[139]  Harold I. Kaplan,et al.  Comprehensive textbook of psychiatry/V , 1989 .

[140]  H. Nasrallah,et al.  Structural brain-imaging findings in affective disorders: an overview. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[141]  J. Krystal,et al.  Psychopharmacology: The Third Generation of Progress , 1989, The Yale Journal of Biology and Medicine.

[142]  F. Walsh,et al.  Alternative splicing generates a secreted form of N-CAM in muscle and brain , 1988, Cell.

[143]  D. Jeste,et al.  Neuroanatomical Studies of Major Affective Disorders , 1988, British Journal of Psychiatry.

[144]  N. Kiriike,et al.  TRH test and DST in schizoaffective mania, mania, and schizophrenia , 1988, Biological Psychiatry.

[145]  L. Major,et al.  Bipolar affective disorder , 1988, Acta psychiatrica Scandinavica.

[146]  K. Nuechterlein,et al.  Family factors and the course of bipolar affective disorder. , 1988, Archives of general psychiatry.

[147]  G. Edelman,et al.  Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. , 1987, Science.

[148]  B. McEwen,et al.  Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.

[149]  T. Rainbow,et al.  Localization and quantification of beta‐adrenergic receptors in human brain , 1986, Neurology.

[150]  J. Palacios,et al.  β-Adrenoceptor subtypes in the human brain: autoradiographic localization , 1985, Brain Research.

[151]  S. Zisook,et al.  The dexamethasone suppression test and unipolar/bipolar distinctions. , 1985, The Journal of clinical psychiatry.

[152]  L. Munsell,et al.  Effects of Systemically Administered Lithium on Phosphoinositide Metabolism in Rat Brain, Kidney, and Testis , 1985, Journal of neurochemistry.

[153]  Emrich Hm.  Endorphins in psychiatry. , 1984 .

[154]  Henry A. Nasrallah,et al.  A histological study of the corpus callosum in chronic schizophrenia , 1983, Psychiatry Research.

[155]  R. Gerner,et al.  Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients , 1982, Brain Research.

[156]  Harold I. Kaplan,et al.  Comprehensive textbook of psychiatry/III , 1980 .

[157]  J. Volavka,et al.  Endorphins in psychiatry: an overview and a hypothesis. , 1978, Archives of general psychiatry.

[158]  F. Goodwin,et al.  VASOPRESSIN IN AFFECTIVE ILLNESS , 1978, The Lancet.

[159]  P. Bech,et al.  Synaptic membrane protein D2 in the cerebrospinal fluid of manic‐melancholic patients , 1977, Acta psychiatrica Scandinavica.

[160]  P. Everall,et al.  Letter: Bowie and Dick test. , 1974, Lancet.

[161]  A. Prange,et al.  L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. , 1974, Archives of general psychiatry.

[162]  J. Forn,et al.  Effects of lithium on brain adenyl cyclase activity. , 1971, Biochemical pharmacology.

[163]  T. Dousa,et al.  Lithium and brain adenyl cyclase. , 1970, Lancet.

[164]  John W. Brazer.  Catecholamine hypothesis of affective disorders , 1969 .

[165]  W. Bunney,et al.  Norepinephrine in depressive reactions. A review. , 1965, Archives of general psychiatry.

[166]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.